hexamethonium has been researched along with Angor Pectoris in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| JUDSON, WE | 1 |
| HOLLANDER, W | 1 |
| SPERANSKII, NI | 1 |
| SOROKINA, EI | 1 |
2 other studies available for hexamethonium and Angor Pectoris
| Article | Year |
|---|---|
The effects of insulin-induced hypoglycemia in patients with angina pectoris; before and after intravenous hexamethonium.
Topics: Angina Pectoris; Cardiovascular Agents; Hexamethonium; Humans; Hyperinsulinism; Hypoglycemia; Insuli | 1956 |
[HEXAMETHONIUM TREATMENT OF PATIENTS WITH SYMPATHETIC GANGLIONITIS WITH ANGINA PECTORIS].
Topics: Angina Pectoris; Autonomic Nervous System; Ganglia; Ganglia, Autonomic; Hexamethonium; Hexamethonium | 1963 |